PTEN and breast carcinoma: Despite our observations of poorer outcomes in patients with PTEN-altered tumors, a 61-year-old breast cancer patient treated in cohort 1 with co-occurring deleterious BRCA1 and PTEN mutations experienced a prolonged PR.